BCL2 and non-small cell lung carcinoma: Bcl-2 has been found to induce tumor growth and confer resistance to chemotherapeutic agents in xenograft models of human non small cell lung cancer (NSCLC) [8-10] and Bcl-2 inhibition seems to contribute to reversal of drug resistance in a variety of cancer cell line models[11,12].